Genocea Biosciences Inc (LTS:0A51)
$ 0.0002 0 (0%) Market Cap: 6,000.00 Enterprise Value: -4.65 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 30/100

Q4 2019 Genocea Biosciences Inc Earnings Call Transcript

Feb 13, 2020 / 01:30PM GMT
Operator

Good morning, ladies and gentlemen, and welcome to the Genocea Fourth Quarter 2019 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mr. Dan Ferry. Go ahead, sir.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, operator, and good morning, everyone. Earlier today, we issued a press release that outlines the topics we plan to discuss today. This release is available at genocea.com under the Investors tab.

During the call today, Chip Clark, President and CEO, will provide a brief corporate update. And the company's Chief Financial Officer, Diantha Duvall, will review the financial results. After their prepared remarks, we will open up the call for Q&A. And Chip; Diantha; Tom Davis, Genocea's Chief Medical Officer; and Jessica Flechtner, Genocea's Chief Scientific Officer will then be available to answer your questions.

Before we begin, I would like to remind everyone that statements made during this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot